[Histological and immunohistochemical diagnosis of bone marrow metastases of neuroblastomas].

Abstract:

:A retrospective, morphological and immunochemical study was performed on 60 bone marrow biopsies (BOM) and 12 tumor specimens surgically excised, from 9 patients with neuroblastoma (NB). Immunochemistry concerned "neuron-specific enolase" (NSE), chromogranin A (CGA) and synaptophysin (SP). The results of immunochemical stains and the study of reticulin network on the argentic stain were compared to the results of morphological evaluation on the routine stain. NSE, CGA and SP staining of tumor cells (part or all of them) was obtained from all surgical specimens. 17/75 BOM (20%) were discarded because of poor material. NB cells were observed in 24 BOM from 3 patients. Tumor cells formed large strands (1 patient) or nests (2 patients) associated with segregated cells. Diagnosis of metastatic BM involvement was negative or doubtful for 6 BOM (3 obtained at the same time, 2 patients), in which NB cells were clearly demonstrated by immunochemical staining of NSE and/or CGA. Reticulin and/or collagen myelofibrosis was present in 32/35 BOM from the 3 patients metastatic in bone marrow (BM+) even if NB cells could not be demonstrated in these samples.

journal_name

Bull Cancer

journal_title

Bulletin du cancer

authors

Boman F,Chastagner P,Floquet J,Sommelet D,Aymard B,Palau R,Kleinclaus I

subject

Has Abstract

pub_date

1991-01-01 00:00:00

pages

943-51

issue

10

eissn

0007-4551

issn

1769-6917

journal_volume

78

pub_type

杂志文章
  • [Radiotherapy of bone metastases].

    abstract::Sixty percent of cancer patients have or develop bone metastases during the development of their cancer. Bone metastases are the most common cause of cancer-related pain. External radiation therapy is the standard treatment of uncomplicated bone metastases, for the treatment of pain, the prevention of fracture, and fo...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1684/bdc.2013.1845

    authors: Leysalle A,Fric D,Lagrange JL,Thariat J

    更新日期:2013-11-01 00:00:00

  • Open-label randomized multi-center phase 2 study: gemcitabine cisplatin plus avelumab or gemcitabine cisplatin as first-line treatment of patients with locally advanced or metastatic urothelial bladder carcinoma: GCisAve.

    abstract:BACKGROUND:The standard treatment in first line of advanced or metastatic urothelial bladder cancer (MBC) is the association of Gemcitabine and Cisplatin (GC). Avelumab, an anti-PD-L1 agent, has recently demonstrated efficacy. The objective is to evaluate the combination of these 3 agents. METHODS:This phase II random...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1016/S0007-4551(20)30280-0

    authors: Gross-Goupil M,Domblides C,Lefort F,Ravaud A

    更新日期:2020-06-01 00:00:00

  • Professional practice and accessibility to equipment in thoracic oncology. Results of a survey in Rhônes-Alpes region (France).

    abstract::This survey, conducted in region Rhône-Alpes (France), aims to assess some data in thoracic oncology practice including availability of specialized equipments. This study is based on a questionnaire mailed to oncologists and pulmonologists in the region. Of 401 questionnaires, the response rate was 56%. Responses of 7...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1684/bdc.2011.1366

    authors: Couraud S,Fournel P,Moro-Sibilot D,Pérol M,Souquet PJ

    更新日期:2011-06-09 00:00:00

  • [Prerequisite for hematopoietic cellular therapy programs to set up chimeric antigen receptor T-cell therapy (CAR T-cells): Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].

    abstract::CAR T-cells are autologous or allogeneic human lymphocytes that are genetically engineered to express a chimeric antigen receptor targeting an antigen expressed on tumor cells such as CD19. CAR T-cells represent a new class of medicinal products, and belong to the broad category of Advanced Therapy Medicinal Products ...

    journal_title:Bulletin du cancer

    pub_type: 共识发展会议,杂志文章,实务指引

    doi:10.1016/j.bulcan.2017.10.017

    authors: Yakoub-Agha I,Ferrand C,Chalandon Y,Ballot C,Castilla Llorente C,Deschamps M,Gauthier J,Labalette M,Larghero J,Maheux C,Moreau AS,Varlet P,Pétillon MO,Pinturaud M,Rubio MT,Chabannon C

    更新日期:2017-12-01 00:00:00

  • [The tobacco-cancer problem].

    abstract::Statistical, biological and chemical data on the carcinogenic effect of tobacco smoke are given and are discussed. The epidemiological studies have clearly shown the particularly noxious action of inhalation, and the direct ratio between the risk and the number of cigarettes smoked. The laboratory experiments on biolo...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Hubert-Habart M

    更新日期:1975-01-01 00:00:00

  • [Molecular (de)regulation and cancer: new therapeutic strategies].

    abstract::The considerable progress of molecular biology within the past twenty years has permitted a more and more detailed characterization of the molecular mechanisms regulating cell proliferation. The corollary to these discoveries has been the identification of different deregulations yielding to cell transformation and ca...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Boulukos KE,Carlotti F,Pognonec P

    更新日期:2001-04-01 00:00:00

  • [Socio-anthropological perspective of the under nutrition care of cancer patients].

    abstract::The diet of the cancer patient is a major focus of prevention and treatment strategy of the recent plans that fight against cancer. It is sometimes reduced to a rapid series of more or less general advice, often interfered by other sources of information, more or less conventional. In this pathological situation where...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1684/bdc.2014.1905

    authors: Fontas M,Poulain JP,Souquet PJ,Laville M,Giboreau A,Bensafi M,Mazières J

    更新日期:2014-03-01 00:00:00

  • [Study of mdm2 gene amplification in primary breast tumors].

    abstract::mdm2 (mouse double minute) protein seems lead to p53 inactivation and therefore might potentially play a role in carcinogenesis. We have studied mdm2 gene amplification from 239 primary breast cancer tissues. mdm2 gene was amplified in 10% of cases (25/239). mdm2 amplification was associated with c-erbB2 amplification...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Fontana X,Ferrari P,Abbes M,Monticelli J,Namer M,Bussière F

    更新日期:1994-07-01 00:00:00

  • [Genetic counseling in cancerology].

    abstract::The evidence that genetic factors are of some importance in the etiology of cancer originates has been determined by genetic epidemiology, molecular biology, cytogenetics. Genetic counselling is one of the possible strategies for controlling cancer through genetics. Genetic counselling in this field more often concern...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Feingold J

    更新日期:1991-01-01 00:00:00

  • [Tumor-stroma interactions].

    abstract::It is widely accepted that the development of carcinoma is not only due to somatic mutations in epithelial cells but also is influenced by the tumor microenvironment ie the stroma. The different stroma components produced growth factors, cytokines, the extra cellular matrix and also participated to the recruitment of ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1684/bdc.2008.0560

    authors: Billottet C,Jouanneau J

    更新日期:2008-01-01 00:00:00

  • Evaluating the influence of prophylactic central neck dissection on TNM staging and the recurrence risk stratification of cN0 differentiated thyroid carcinoma.

    abstract:OBJECTIVE:The purpose of this study was to explore the risk factors that were associated with central lymph node metastasis (CLNM) in patients with clinical nodal negative differentiated thyroid carcinoma (cN0 DTC) after prophylactic central neck dissection (pCND). The influence of pCND on TNM staging and recurrence ri...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1016/j.bulcan.2016.04.003

    authors: Lin X,Chen X,Jiru Y,Du J,Zhao G,Wu Z

    更新日期:2016-06-01 00:00:00

  • [Stereotactic radiosurgery and radiotherapy for brain metastases].

    abstract::Brain metastases management is still controversial even though many trials are trying to define the respective roles of neurosurgery, whole-brain radiotherapy, single-dose stereotactic radiotherapy and fractionated stereotactic radiotherapy. In this article, we review data from trials that examine the role of radiosur...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1684/bdc.2012.1683

    authors: Tanguy R,Métellus P,Mornex F,Mazeron JJ

    更新日期:2013-01-01 00:00:00

  • [Dynamic characterization of the growth of brain tumors based on image sequences of nuclear magnetic resonance].

    abstract::The evolution of a high grade glioblastoma of a patient undergoing radio-therapy has been analysed by considering a mathematical model which simulates the brain tumour growth within a two-dimensional domain defined by the brain and ventricles geometry. This simulated behaviour was compared with morphological data obta...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Tracqui P,Leitner F,Esteve F

    更新日期:1995-12-01 00:00:00

  • [The frequency of cancer in France in year 2002, and trends since 1968].

    abstract::The estimated number of cancers diagnosed in 2002 is 150,000 in the male population and 120,000 in the female population and there were close to 88,000 cancer deaths among men and 59,000 cancer deaths among women in France. The most frequent cancer sites in the male population are prostate, lung, colon, intestine and ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Hill C,Doyon F

    更新日期:2006-01-01 00:00:00

  • [Recent therapeutic trends in triple-negative metastatic breast cancers: PARP inhibitors, immunotherapies and antibody-drug conjugates].

    abstract::Compared with other breast cancer subtypes, patients with metastatic triple-negative breast cancer (TNBC) are younger and have a worst overall survival with a median of 15 to 18 months. These tumors have long suffered from a purely negative definition, but the last few years have witnessed many breakthrough genomic an...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1016/j.bulcan.2020.11.007

    authors: Dalenc F,Sarradin V,Nicolaï V,Franchet C,Ung M

    更新日期:2021-01-01 00:00:00

  • [Gene therapy of primary cancers of the liver: hopes and realities].

    abstract::Many efforts have been devoted to the development of gene therapy for primary liver tumors. This has been hampered by the absence of efficient gene transfer vectors for delivering genes into hepatoma cells in vivo. Also it remains to determine which type of gene has to be used to achieve complete tumor regression. Rec...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Ferry N

    更新日期:1997-04-01 00:00:00

  • [Mendelian genetics and cancer (author's transl)].

    abstract::Two hundred different mendelian genes can have a cancerogenic effect in man, but it is difficult to make out between the genetic and the environmental part. Acute lymphoblastic leukemia is an example that the actual cancerogenic factor can be environmental and not genetic. Genetically controlled tumors can result from...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Amiel JL

    更新日期:1978-01-01 00:00:00

  • [Squamous cell anal carcinoma. What's next ?]

    abstract::Despite its status as a rare disease, the incidence of the squamous cell carcinoma of the anus (SCCA) is surging, especially in its metastatic form. In addition, the prognosis of initially localized diseases has not substantially changed since the 1970s with a recurrence rate of between 25-40 % after the chemoradiothe...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1016/j.bulcan.2020.12.001

    authors: Kim S,Spehner L,Cabel L,Bidard FC,Borg C

    更新日期:2021-01-01 00:00:00

  • Nouvelles perspectives dans l’immunothérapie des cancers.

    abstract:NOVEL PERSPECTIVES IN CANCER IMMUNOTHERAPIES:Š. ...

    journal_title:Bulletin du cancer

    pub_type: 社论

    doi:10.1016/S0007-4551(18)30384-9

    authors: Caux C,Bay JO

    更新日期:2018-12-01 00:00:00

  • [Cytotoxicity of tamoxifen and its principal metabolites in human breast cancer cell lines].

    abstract::The antiestrogen tamoxifen (TAM) has been successfully used to treat breast cancer expressing estrogen and progesterone receptors (ER+ and PR+). However, the development of antiestrogen resistance is frequently observed in patients following long-term treatment. To better understand the mechanism of action of TAM and ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Bachmann-Moisson N,Barberi-Heyob M,Merlin JL,Ledrich ML,Batt AM,Guillemin F

    更新日期:1996-10-01 00:00:00

  • [Endothelin receptors in benign human tumours of uterine muscle].

    abstract::The endothelins (ET1, ET2, ET3) are a family of peptides that exert vasoactive and mitogenic effects. ETs bind to at least two subtypes of receptors: the ETA subtype is ET1 selective whereas the ETB subtype binds ET1, ET2 and ET3. By RT-PCR, we detected ETA receptor mRNA and ETB receptor mRNA in leiomyoma and in homol...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Breuiller-Fouché M,Honoré JC,Robert B,Fournier T,Vacher-Lavenu MC,Chapron C,Dubuisson JB,Ferré F

    更新日期:1999-09-01 00:00:00

  • [Patients on oral anticancer drugs and coordinated pathway: CHIMORAL, feedback from care providers].

    abstract:INTRODUCTION:Oral anticancer drugs have raised the question of how to follow-up these patients and how to coordinate this follow-up. The CHIMORAL study evaluated the involvement of primary care providers and a coordination by territorial health networks. Training/information tools were provided, as well as weekly nursi...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1016/j.bulcan.2020.08.014

    authors: Maritaz C,Napoly L,Burnel S,Lotz JP

    更新日期:2020-12-01 00:00:00

  • [Melanomas of the female genital tract: state of the art].

    abstract::Melanoma of the female genital tract is a rare location (less than 2% of melanomas all sites combined). These cancers have a very poor prognosis, due to the delay in diagnosis. Vulvar location is about 1% of melanomas then the vaginal location, uterine and ovarian. There is no consensus to date regarding their care, d...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1684/bdc.2013.1881

    authors: Trone JC,Guy JB,Mery B,Langrand Escure J,Lahmar R,Moncharmont C,Rivoirard R,Semay T,Chauleur C,Collard O,Vignot S,Magné N

    更新日期:2014-01-01 00:00:00

  • [Cancer of the uterine cervix in young women. A retrospective study of 337 cases].

    abstract::A retrospective study of 337 cases of cervix cancers in women aged 35 years and under, treated between 1980-1990 at the Ibn Rochd Oncology Center in Casablanca, was analyzed in order to determine the main characteristics of this disease and the influence of age on prognosis. The incidence of these cases was stable thr...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Acharki A,Sahraoui S,Benider A,Tawfiq N,Jouhadi H,Bouras N,Samlali R,Kahlain A

    更新日期:1997-04-01 00:00:00

  • High negative predictive value of slow lymphatic drainage on metastatic node spread detection in malignant limb and trunk cutaneous melanoma.

    abstract:AIM:Harvesting of the "sentinel lymph node" (SLN) as identified by lymphoscintigraphy (LSG) is becoming increasingly important in the staging of patients with malignant melanoma. The purpose of the current study was to determine whether the appearance time of the LSG had a prognostic value in predicting metastasis diss...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Cammilleri S,Jacob T,Rojat-Habib MC,Hesse S,Berthet B,Giorgi R,Bonerandi JJ,Mundler O

    更新日期:2004-07-01 00:00:00

  • [Methodology and limitations of pre-clinical models for the development of anticarcinogenic chemotherapy combinations].

    abstract::In chemosensitive tumors, cancer chemotherapy is active as drug combinations. During the development of new anticancer drugs, preclinical experimental models may help to design drug combinations. Indeed, in vitro models are able to define drug interactions in terms of synergism, additivity or antagonism, while in vivo...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Vassal G

    更新日期:1998-11-01 00:00:00

  • [Protontherapy: basis, indications and new technologies].

    abstract::With over 70,000 patients treated worldwide, protontherapy has an evolution on their clinical applications and technological developments. The ballistic advantage of the Bragg peak gives the possibility of getting a high conformation of the dose distribution to the target volume. Protontherapy has accumulated a consid...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1684/bdc.2010.1149

    authors: Mazal A,Habrand JL,Delacroix S,Datchary J,Dendale R,Desjardins L,Ferrand R,Malka V,Fourquet A

    更新日期:2010-07-01 00:00:00

  • [Management of febrile neutropenias in adolescents and young adults: Differences of practice between adult and pediatric units].

    abstract:INTRODUCTION:Adolescents and young adults (AYA, 15-25years old) with cancer are treated either in adult or pediatric units. Management of febrile neutropenia (FN) is different between these units. Monitoring rules and indications of hospitalization are often stricter in pediatrics. This study evaluates if these differe...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1016/j.bulcan.2015.08.001

    authors: Penel-Page M,Normand C,Bertrand A,Levard A,Boyle H,Riberon C,Marec-Berard P

    更新日期:2015-11-01 00:00:00

  • [Cancer and pregnancy: the point of view of the chemotherapy oncologist].

    abstract::Having to start chemotherapy during pregnancy remains a rare event. The decision to proceed this treatment relies on the drugs used, the time of exposure for the foetus and the gestational age at the time of exposure. As a matter of fact, the mutagenicity potential of the chosen medicine has to be known, and consequen...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Pautier P,Lhomme C,Morice P

    更新日期:2002-09-01 00:00:00

  • [Statistical study of a series of 672 cases of carcinoma of the uterine cervix. Results and complications according to age and modalities of treatment].

    abstract::The study bears on 672 infiltrating carcinomas of the cervix treated from 1977 until the end of 1991, by a radiosurgical combination (311 patients) or by exclusive irradiation (361 patients). The radiosurgical series includes mostly stages IB and II and patients under 50 years because of the therapeutic protocol. Most...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Pernot M,Hoffstetter S,Peiffert D,Carolus JM,Guillemin F,Verhaeghe JL,Marchal C,Luporsi E,Beckendorf V,Stines J

    更新日期:1995-07-01 00:00:00